Quintiles is the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide. Our 20,000 engaged professionals in 60 countries work with an unwavering commitment to patients, safety and ethics. With almost $3 billion in annual revenue, Quintiles is the world’s leading provider of services to the biopharmaceutical industry.
Quintiles helps biopharma companies navigate risk and seize opportunities in an environment where change is constant, which we describe as the New Health.
Quintiles Transnational has plenty to CRO about. One of the world's largest contract research organizations (CROs), it helps pharmaceutical, biotechnology, and medical device companies develop and sell their products. The firm provides a comprehensive range of clinical trials management services, including patient recruitment, data analysis, laboratory testing, and regulatory filing assistance. Its consulting unit offers strategic advice at every stage of drug discovery and development, and its capital and commercial divisions assist with project funding and sales and marketing efforts. Quintiles, which has been a private company since 2003, filed an IPO in February 2013.
4820 Emperor Boulevard
Durham, NC 27703